KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Net Income towards Common Stockholders (2016 - 2025)

Merck (MRK) has disclosed Net Income towards Common Stockholders for 16 consecutive years, with $3.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 20.86% to $3.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $18.3 billion, a 6.59% increase, with the full-year FY2025 number at $18.3 billion, up 6.6% from a year prior.
  • Net Income towards Common Stockholders was $3.0 billion for Q4 2025 at Merck, down from $5.8 billion in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $5.8 billion in Q3 2025 to a low of -$6.0 billion in Q2 2023.
  • A 4-year average of $2.4 billion and a median of $3.2 billion in 2024 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: plummeted 111.28% in 2021, then soared 415.15% in 2024.
  • Merck's Net Income towards Common Stockholders stood at -$59.0 million in 2021, then tumbled by 1913.56% to -$1.2 billion in 2023, then skyrocketed by 415.15% to $3.7 billion in 2024, then decreased by 20.86% to $3.0 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Net Income towards Common Stockholders are $3.0 billion (Q4 2025), $5.8 billion (Q3 2025), and $4.4 billion (Q2 2025).